Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men

Autor: Rodolfo Guadron, Lembitu Sorra, Daniel Bowers, Benjamin Asriel, Antonio Urbina, Rachel Chasan, Jose Fefer, Terry Farrow, Larisa Litvinova, Sneha Jacob, Susan Hefron, Francis Wallach, Richie Tran, Eddie Meraz, Eric Leach, Charles Paolino, Randy Levine, Michael M. Gaisa, Punyadech Photangtham, Jesse R Carollo, George Psevdos, Nirupama Somasundaram, Jeffrey C. Kwong, Eileen Donlon, Livette Johnson, Ricky Hsu, Ahmed El Sayed, Susanne Burger, Gal Mayer, Daniel S. Fierer, Lawrence Hitzeman, Susan Weiss, Rona Vail, Martin Markowitz, Wen Wang, Patrick Dalton, Paari M Palaniswami, Melissa Wiener, Asa Radix, Krisczar Bungay, Lawrence Higgins, Amisha Malhotra, Erik Mortensen, William Mandell, Victor Inada, Stuart Haber, Oscar Klein, John Dellosso, Gabriela Rodriguez-Caprio, William Shay, Joseph Olivieri, SI Rapaport, Robert Cohen, Stephen Dillon, Jose Lares-Guia, Paul C. Bellman, Rita Chow, Donald Kaminsky, Juan Bailey, Roona Ray, Robert Chavez, Aviva Cantor, Shirish Huprikar, Irina Linetskaya, Barbara Johnston, Bisher Akil

Publikováno v: Open Forum Infectious Diseases

Background Treatment of HIV-infected men during early hepatitis C virus (HCV) infection with interferon results in a higher cure rate with a shorter duration of treatment than during chronic HCV infection. We recently demonstrated that this phenomeno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb88d52d9aaf4d213a7f31b15de22c3c
https://doi.org/10.1093/ofid/ofy238